Kono R, Sasagawa A, Miyamura K, Tajiri E
Am J Epidemiol. 1975 May;101(5):444-57. doi: 10.1093/oxfordjournals.aje.a112112.
Serologic and sero-epidemiologic characteristics of AHC virus infection were studied by neutralization test (NT). Four-fold or greater virus neutralizing (VN) antibody response was demonstrated to the Japanese isolate of AHC virus (the J 670/71 strain) in 77.3% and 66.7% of paired sera from clinical AHC patients in Japan (1971-1973) and Tunisia (1973). The four patients from Indonesia studied in 1972 showed similar antibody response. Cross-neutralization tests of AHC virus isolated in Japan (1971), Taiwan (1971), Hong Kong (1971), Thailand (1972), Indonesia (1972), Singapore (1972), Morocco (1971) and England (1971) with three kinds of antisera prepared against Japanese, Hong Kong and Moroccan AHC virus isolates indicated their antigenic identity. However, isolates from Sinapore in 1970 (Singapore 70 virus) were not neutralized with the AHC virus antisera mentioned above: Singapore 70 virus constitutes another antigenic type, to which, however, no VN antibody rise was found in paired patients' sera from Japan, Tunisia and Indonesia. Thus, no serologic evidence supporting an etiologic role of this virus group in the development of AHC was found. Although cross-tests using monospecific antisera suggested some cross-relation between AHC and both echovirus type 4 (E4) and coxsackie A (CA), type 19, no serologic relationship between AHC and these viruses was found. Sera from healthy individuals collected before and after AHC outbreaks were tested for VN antibody against AHC virus in Japan and two epidemic foci, Ghana and Indonesia. Before the epidemic, 80 to 90% of the people lacked antibody in the three countries, but 39.7% and 45.2% of inhabitants posessed VN antibody of 1:8 or over in Ghana and Indonesia after the outbreak. In Japan, however, only a slight increase was found in VN antibody prevalence afterwards. Serologic study showed that 41.5% of horse sera were VN positive at dilutions of 1:8 or more; many cattle sera also had a low VN titer but few cynomologus monkey sera had VN activity.
通过中和试验(NT)研究了AHC病毒感染的血清学和血清流行病学特征。在日本(1971 - 1973年)和突尼斯(1973年)临床AHC患者的成对血清中,分别有77.3%和66.7%对日本分离的AHC病毒(J 670/71株)呈现四倍或更高的病毒中和(VN)抗体反应。1972年研究的4名印度尼西亚患者也表现出类似的抗体反应。对1971年在日本、1971年在台湾、1971年在香港、1972年在泰国、1972年在印度尼西亚、1972年在新加坡、1971年在摩洛哥和1971年在英国分离的AHC病毒,用针对日本、香港和摩洛哥AHC病毒分离株制备的三种抗血清进行交叉中和试验,结果表明它们具有抗原同一性。然而,1970年来自新加坡的分离株(新加坡70病毒)不能被上述AHC病毒抗血清中和:新加坡70病毒构成另一种抗原型,不过在日本、突尼斯和印度尼西亚患者的成对血清中未发现VN抗体升高。因此,未发现支持该病毒组在AHC发病中起病因作用的血清学证据。尽管使用单特异性抗血清的交叉试验表明AHC与埃可病毒4型(E4)和柯萨奇A组(CA)19型之间存在一些交叉关系,但未发现AHC与这些病毒之间的血清学关系。在日本以及加纳和印度尼西亚的两个疫情点,对AHC疫情前后收集的健康个体血清进行了针对AHC病毒的VN抗体检测。疫情前,这三个国家80%至90%的人缺乏抗体,但疫情后加纳和印度尼西亚分别有39.7%和45.2%的居民拥有1:8或更高的VN抗体。然而,在日本,此后VN抗体流行率仅略有增加。血清学研究表明,41.5%的马血清在1:8或更高稀释度时VN呈阳性;许多牛血清也有较低的VN滴度,但很少有食蟹猴血清具有VN活性。